AIM: To evaluate the role of CHADS2 and CHA2DS2-VASc scores in predicting the risk of ischemic stroke or transient ischemic attack (TIA) outcomes in patients with interatrial block (IAB) without a history of atrial fibrillation (AF). METHODS: A retrospective study was conducted, including 1,046 non-anticoagulated inpatients (612 males, 434 females; mean age: 63±10 years) with IAB and without AF. IAB was defined as P-wave duration ＞120 ms using a 12-lead electrocardiogram. CHADS2 and CHA2DS2-VASc scores were retrospectively calculated. The primary outcomes evaluated were ischemic stroke or TIA. RESULTS: During the mean follow-up period of 4.9±0.7 years, 55 (5.3%) patients had an ischemic stroke or TIA. Receiver operating characteristic (ROC) curve analysis showed that the CHADS2 score [area under the curve (AUC), 0.638; 95% confidence interval (CI), 0.562-0.715; P=0.001] and the CHA2DS2-VASc score (AUC, 0.671; 95% CI, 0.599-0.744; P＜0.001) were predictive of ischemic strokes or TIA. Cut-off point analysis showed that a CHADS2 score ≥3 (sensitivity=0.455 and specificity=0.747) and a CHA2DS2-VASc score ≥4 (sensitivity=0.564 and specificity=0.700) provided the highest predictive value for ischemic stroke or TIA. The multivariate Cox regression analysis showed that CHADS2 [hazard ratio (HR), 1.442; 95% CI, 1.171-1.774; P=0.001] and CHA2DS2-VASc (HR, 1.420; 95% CI, 1.203-1.677; P＜0.001) scores were independently associated with ischemic stroke or TIA following adjustment for smoking, left atrial diameter, antiplatelet agents, angiotensin inhibitors, and statins. CONCLUSIONS: CHADS2 and CHA2DS2-VASc scores may be predictors of risk of ischemic stroke or TIA in patients with IAB without AF.
AIM: To evaluate the role of CHADS2 and CHA2DS2-VASc scores in predicting the risk of ischemic stroke or transient ischemic attack (TIA) outcomes in patients with interatrial block (IAB) without a history of atrial fibrillation (AF). METHODS: A retrospective study was conducted, including 1,046 non-anticoagulated inpatients (612 males, 434 females; mean age: 63±10 years) with IAB and without AF. IAB was defined as P-wave duration ＞120 ms using a 12-lead electrocardiogram. CHADS2 and CHA2DS2-VASc scores were retrospectively calculated. The primary outcomes evaluated were ischemic stroke or TIA. RESULTS: During the mean follow-up period of 4.9±0.7 years, 55 (5.3%) patients had an ischemic stroke or TIA. Receiver operating characteristic (ROC) curve analysis showed that the CHADS2 score [area under the curve (AUC), 0.638; 95% confidence interval (CI), 0.562-0.715; P=0.001] and the CHA2DS2-VASc score (AUC, 0.671; 95% CI, 0.599-0.744; P＜0.001) were predictive of ischemic strokes or TIA. Cut-off point analysis showed that a CHADS2 score ≥3 (sensitivity=0.455 and specificity=0.747) and a CHA2DS2-VASc score ≥4 (sensitivity=0.564 and specificity=0.700) provided the highest predictive value for ischemic stroke or TIA. The multivariate Cox regression analysis showed that CHADS2 [hazard ratio (HR), 1.442; 95% CI, 1.171-1.774; P=0.001] and CHA2DS2-VASc (HR, 1.420; 95% CI, 1.203-1.677; P＜0.001) scores were independently associated with ischemic stroke or TIA following adjustment for smoking, left atrial diameter, antiplatelet agents, angiotensin inhibitors, and statins. CONCLUSIONS: CHADS2 and CHA2DS2-VASc scores may be predictors of risk of ischemic stroke or TIA in patients with IAB without AF.
Authors: Sante D Pierdomenico; Anna M Pierdomenico; Silvio Di Carlo; Roberta Di Tommaso; Franco Cuccurullo Journal: Am J Hypertens Date: 2014-03-28 Impact factor: 2.689
Authors: Teresa S M Tsang; Marion E Barnes; Walter P Abhayaratna; Steven S Cha; Bernard J Gersh; Andrew P Langins; Tammy D Green; Kent R Bailey; Yoko Miyasaka; James B Seward Journal: Am J Cardiol Date: 2006-02-03 Impact factor: 2.778
Authors: Antoni Bayés de Luna; Adrian Baranchuk; Manuel Martínez-Sellés; Pyotr G Platonov Journal: Ann Noninvasive Electrocardiol Date: 2016-12-16 Impact factor: 1.468
Authors: Antonio Bayés de Luna; Adrián Baranchuk; César Niño Pulido; Manuel Martínez-Sellés; Antonio Bayés-Genís; Roberto Elosua; Marcelo V Elizari Journal: Ann Noninvasive Electrocardiol Date: 2018-09-02 Impact factor: 1.468
Authors: Göksel Çinier; Ahmet İlker Tekkeşin; Tuğba Yanar Çelik; Özlem Mercan; Halil İbrahim Tanboğa; Muhammed Burak Günay; Ceyhan Türkkan; Mert İlker Hayıroğlu; Bryce Alexander; Ahmet Taha Alper; Adrian Baranchuk Journal: J Atr Fibrillation Date: 2018-10-31
Authors: Antoni Bayés de Luna; Manuel Martínez-Sellés; Antoni Bayés-Genís; Roberto Elosua; Adrian Baranchuk Journal: BMC Cardiovasc Disord Date: 2017-07-31 Impact factor: 2.298